Food and Drugs Act, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
Schedules to the Patent Act related to Canada's Access to Medicines Regime, specifically, Schedules 1, 2, 3 and 4
Policies or Program
Canada's strategic objectives and initiatives related to the Global Fund to Fight AIDS, Tuberculosis and Malaria
Food and Drugs Act administration, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
Health Canada and Public Health Agency of Canada policies and programs to eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy
Health Canada's office of pharmaceutical management strategies, particularly as it relates to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
Input on the work of the Advisory Committee on the Implementation of National Pharmacare, specifically as it relates to the evaluation and funding of medicines
The development of a national pharmacare program, including the Canada Drug Agency, a national formulary and a rare diseases strategy
Policies or Program, Regulation
Regulations, guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Regulation
Amendments to the Patented Medicines Regulations published in Canada Gazette, Part II on August 21, 2019 and June 10, 2020.
Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
Food and Drugs Act Regulations, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
Health Canada Legislative and Regulatory Modernization initiatives as related to the regulation and life-cycle management of therapeutic products
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations and the administration of those regulations by Health Canada and Industry Canada
Regulations Amending the Food and Drug Regulations (FDR) (1402 - Drugs for Developing Countries) related to Canada's Access to Medicines Regime